聯創股份(300343.SZ):聚合物基固態電解質材料的研發尚處於前期小試階段
格隆匯2月24日丨聯創股份(300343.SZ)在投資者互動平臺表示,公司與中山大學合作共同研究開發高性能聚合物基固態電解質材料,在初期研發過程中獲得“一種軟硬段結合的含雙增塑劑的交聯聚合物基準固態電解質及其製備方法和應用”“ 一種二氧化碳基(聚碳酸酯-聚脲)嵌段共聚物固態電解質及其製備方法”“ 一種雙連續相共晶聚合物固態電解質及軟包電池和製備方法”三項關於固態電解質的專利授權。聚合物基固態電解質材料的研發尚處於前期小試階段,暫時尚不具備產業化條件,該項目短期內不會對公司收益產生影響,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.